|4Apr 5, 8:17 AM ET

Duvall Diantha 4

4 · GENOCEA BIOSCIENCES, INC. · Filed Apr 5, 2022

Insider Transaction Report

Form 4
Period: 2022-04-04
Duvall Diantha
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    2022-04-04$1.25/sh963$1,20491,775 total
Footnotes (1)
  • [F1]Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.

Documents

1 file
  • 4
    wf-form4_164916106048565.xmlPrimary

    FORM 4